Summary

The drug screening market in India has grown substantially as a result of growing awareness of substance usage, stringent regulatory frameworks, and the implementation of drug screening policies across numerous sectors. The market is predicted to grow further, owing to reasons such as workplace testing, government initiatives, and healthcare screenings. Several government efforts in India are aimed at reducing drug misuse and fostering a drug-free society. Stringent rules require drug testing in workplaces, educational institutions, and other sectors, which contributes to market growth. The Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, governs the sale and usage of drug screening kits in India. The sale of these items is restricted to licenced medical professionals and authorised institutions under this act. The Indian drug screening industry is expected to expand significantly in the future. Technological advancements, such as non-invasive testing procedures and telemedicine integration, have the potential to further revolutionise the sector. Increasing understanding and appropriate usage of these goods can help India become a safer and healthier place. The enormous and diversified population of India brings new challenges and opportunities for drug screening. The sheer size necessitates a variety of ways to adapt to various locations, cultural quirks, and socioeconomic backgrounds. In the Indian market, affordability is key to reach a larger percentage of the population, drug screening solutions must be cost-effective, particularly in workplaces, educational institutions, and public health programmes. The drug screening industry in India is highly competitive, with both domestic and international competitors contending for market dominance. Competitive pressure fosters innovation, pricing strategies, and service quality.

According to the research report "India Drug Screening Market Overview, 2028," published by Bonafide Research, the India Drug Screening market is expected to grow with more than 12% CAGR from 2023 to 2028. The market for drug screening is predicted to increase significantly as India's healthcare infrastructure improves and awareness about drug usage grows, offering potential for new technology and services. Disparities in accessibility and adoption of drug screening procedures exist between urban and rural communities. It is critical to tailor methods for these various contexts. The Indian government is putting more emphasis on public health initiatives. These activities are aligned with drug screening, which emphasises preventive healthcare and substance misuse management. In India's drug screening business, affordability and cost sensitivity are critical. In order to reach a larger segment of the population, solutions must be economically viable. To achieve widespread acceptance and compliance, employers, educational institutions, and public health programmes must employ cost-effective screening procedures. The fast adoption of technological advancements in India, particularly in the healthcare sector, is changing traditional approaches to drug screening. Adopting digital health solutions, advances in healthcare technology, and the incorporation of AI and data analytics all have a big impact on the evolution of drug screening methods in the country. The demand for and method of drug screening in India is influenced by the country's different cultural attitudes towards drug usage. It is critical for successful implementation to be sensitive to these cultural variations while also addressing privacy concerns. Balancing the necessity of screening with individual privacy and community standards is still an important topic. Drug testing is not limited to the workplace; it is also used in healthcare facilities, law enforcement, education, and sports. The growing emphasis in India on public health programmes, preventative healthcare, and substance misuse management fits with the larger uses of drug screening, opening up prospects for integration into a variety of industries.

Based on product and service segment market is divided into consumables, analytical instruments, rapid testing devices, and drug screening service. Analytical instruments are gaining significant traction in India drug screening market. Analytical instruments include innovative technologies such as chromatography, mass spectrometry, and immunoassays. These provide greater precision, sensitivity, and specificity in identifying a wide spectrum of substances and their metabolites. As advanced analytical devices can detect tiny levels of chemicals, screening findings are more thorough and exact. Analytical instruments are versatile, meeting a wide range of testing requirements in industries such as healthcare, workplaces, law enforcement, and sports. They can handle a wide range of sample types and testing procedures, meeting the needs of various end-users. The growing need for drug screening services, paired with India's healthcare sector's growth potential, drives investments in modern analytical tools. Companies are recognising the potential of this industry and investing in technology to meet changing expectations. Companies and research organisations are always investing in R&D to create newer, more efficient analytical tools designed specifically for drug screening. This continual innovation drives market adoption of these devices. The sample type of the market is segmented into urine samples, breath samples, hair samples, oral fluid samples, and other samples. Oral fluid samples are projected to grow at rapid pace in India drug screening market. Oral fluid samples are non-invasive and easy to obtain, making them more acceptable and comfortable for people undergoing drug testing. This ease of collecting fosters higher compliance rates, particularly in circumstances requiring frequent or on-the-spot testing. Oral fluid testing procedures have become more accurate and reliable as technology has advanced. Innovative technologies and assays provide faster results without sacrificing accuracy, making them appealing for a wide range of testing scenarios. Regulatory organisations have accepted oral fluid testing procedures for drug screening reasons. Their dependability and efficacy in identifying a wide range of drugs have improved trust in their use for compliance and regulatory needs.

Based on end user segment market is bifurcated into laboratories, workplaces, hospitals, and others. Hospitals are one of the major end users of drug screening product and service in India drug screening market. Drug screening in hospitals is necessary for diagnostic purposes, particularly when drug usage can impact treatment outcomes or when medication adherence is critical for patient management. Hospitals frequently confront emergency situations that necessitate urgent drug testing. Rapid point-of-care testing enables rapid assessments and urgent medical actions. Screening for substance abuse before surgery is critical for avoiding complications and ensuring patient safety during treatments. Preoperative drug screening is a regular procedure in hospitals. Drug screening is consistent with the broader idea of delivering holistic healthcare, which addresses not only the medical problem but also drug addiction issues, that impact patient well-being. Hospitals involved in medical research and clinical trials require drug screening to ensure participant eligibility and monitor drug effects during trials.

Considered in this report:
• Geography: India
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• India Drug Screening market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product and Service:
• Consumables
• Analytical Instruments
• Rapid Testing Devices
• Drug Screening Service

By Sample Type:
• Urine Samples
• Breath Samples
• Hair Samples
• Oral Fluid Samples
• Other Samples

By End User:
• Laboratories
• Workplaces
• Hospitals
• Others

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drug Screening industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents